In the present study, we revealed that inhibiting lipolysis by targeting ATGL in VAT from obese mice and humans with obesity with respective inhibitors ex vivo prevented VAT-induced impairment of Kir2.1. This evidence concerns the gene KCNJ2 and obesity disorder.